Tech Company Financing Transactions
Avila Therapeutics Funding Round
Private investors participated in a $5 million venture round for Avila Therapeutics. The round was announced on 5/18/2009.
Transaction Overview
Company Name
Announced On
5/18/2009
Transaction Type
Debt
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
45 Wiggins Ave.
Bedford, MA 01730
USA
Bedford, MA 01730
USA
Phone
Website
Email Address
Overview
Avila Therapeutics, Inc., is a venture-backed company focused on the discovery and development of novel small molecule therapeutics to address significant unmet clinical needs with an initial focus on cancer and viral diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Katrine Bosley
Chief Scientific Officer
Juswinder Singh
VP - Operations
Nagesh Mahanthappa
Browse more venture capital transactions:
Prev: 5/18/2009: StockTwits venture capital transaction
Next: 5/19/2009: Elixir Pharmaceuticals venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs